P. Albertsen, J. Hanley, and J. Fine, 20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer, JAMA, vol.293, issue.17, pp.2095-101, 2005.
DOI : 10.1001/jama.293.17.2095

H. Welch and W. Black, Overdiagnosis in Cancer, JNCI Journal of the National Cancer Institute, vol.355, issue.17, pp.605-618, 2010.
DOI : 10.1056/NEJMoa060476

URL : https://academic.oup.com/jnci/article-pdf/102/9/605/17311101/djq099.pdf

L. Klotz, D. Vesprini, P. Sethukavalan, V. Jethava, L. Zhang et al., Longterm follow-up of a large active surveillance cohort of patients with prostate cancer, J

R. Thomas, Active surveillance of prostate cancer in African American men

P. Kheirandish and F. Chinegwundoh, Ethnic differences in prostate cancer, British Journal of Cancer, vol.4, issue.4, pp.481-486, 2009.
DOI : 10.1038/ng2022

S. Mallick, P. Blanchet, and L. Multigner, Prostate Cancer Incidence in Guadeloupe, a French Caribbean Archipelago, European Urology, vol.47, issue.6, pp.769-72, 2005.
DOI : 10.1016/j.eururo.2005.02.020

. Antilles-guyane, Available from: http://www.invs.sante.fr/fr/Publications-et-outils/Bulletin-de-veille-sanitaire/Tous-lesnumeros/Antilles-Guyane/Bulletin-de-veille-sanitaire-Antilles-Guyane, Publications et outils / Accueil [Internet]. [cited 2016 May 9]

M. Cooperberg, J. Hilton, and P. Carroll, The CAPRA-S score, Cancer, vol.60, issue.3 suppl 1, pp.5039-5085, 2011.
DOI : 10.1016/S0090-4295(02)01585-6

S. Bruinsma, C. Bangma, P. Carroll, M. Leapman, A. Rannikko et al., Active surveillance for prostate cancer: a narrative review of clinical guidelines, Nature Reviews Urology, vol.63, issue.3
DOI : 10.1136/bmj.311.7001.376

V. Iremashvili, M. Soloway, D. Rosenberg, and M. Manoharan, Clinical and Demographic Characteristics Associated With Prostate Cancer Progression in Patients on Active Surveillance, The Journal of Urology, vol.187, issue.5, pp.1594-1603
DOI : 10.1016/j.juro.2011.12.082

M. Abern, M. Bassett, M. Tsivian, L. Bañez, T. Polascik et al., Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center, Prostate Cancer and Prostatic Diseases, vol.96, issue.1, 2013.
DOI : 10.1200/JCO.2010.33.0134

O. Kryvenko, R. Balise, S. Prakash, N. Epstein, and J. , African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance, The Journal of Urology, vol.195, issue.2, 2016.
DOI : 10.1016/j.juro.2015.08.089

I. Nccn-guidelines, Prostate Cancer Early Detection, Version 2.2016, J Natl Compr Cancer Netw JNCCN. 2016, vol.14, issue.5, pp.509-528

I. Powell, G. Dyson, S. Land, J. Ruterbusch, C. Bock et al., Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, pp.891-898, 2013.

C. Magi-galluzzi, T. Tsusuki, P. Elson, K. Simmerman, C. Lafargue et al., TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients, The Prostate, vol.102, issue.3, pp.489-97, 2011.
DOI : 10.1038/sj.bjc.6605519